Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
Published in:
Transfuze Hematol. dnes,17, 2011, No. 4, p. 191-192.
Category:
Selection of press reports and books
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2011 Issue 4
Most read in this issue
- Bone marrow microenvironment and its role in the pathogenesis of leukaemia
- Donor lymphocyte collections from unrelated donors of the Czech National Marrow Donors Registry (ČNMDR) between 1999 and 2010
- Serum levels of immunoglobulin free light chains in monoclonal gammopathy of undetermined significance and their contribution to stratification and monitoring
- Randomized, double-blind trial of fluconazole versus variconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation